RxDoctor Payments Data

Christopher Drinkwater, MD

Adult Reconstructive Orthopaedic Surgery · Rochester, NYNPI 1033150966

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $43,241 of the $52,007 with a category attached, or 83.1%. Medical Device Business Services, Inc. accounts for 77.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $21,837 and has fallen 98.4% since, to $349 in 2025.

$52,007in general payments, 2019–2025

Across 83 payments — averaging $626.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$40K
  • Depuy Synthes Products, Inc.$9K
  • Johnson & Johnson$1K
  • Stryker$720
  • Zimmer Biomet$260
  • Smith+Nephew$142
  • plus $187 from 3 others
$84,890in research payments, 2019–2025

Across 28 payments — averaging $3031.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$85K

What the payments were for

  • Consulting fees$43,24183%
  • Travel & lodging$6,04912%
  • Food & beverage$2,7185%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,007 in reported general payments places this provider in the 70th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$90,087
Medicare patients
103
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult reconstructive orthopaedic surgery in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →